These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2046193)

  • 1. [Correlations between nuclear DNA content and nuclear morphometry versus histological grading of prostatic carcinoma].
    Murayama M; Kameya T; Kakehi R
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):110-6. PubMed ID: 2046193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear/Nucleolar morphometry and DNA image cytometry as a combined diagnostic tool in pathology of prostatic carcinoma.
    Kavantzas N; Agapitos E; Lazaris AC; Pavlopoulos PM; Sofikitis N; Davaris P
    J Exp Clin Cancer Res; 2001 Dec; 20(4):537-42. PubMed ID: 11876548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
    Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA analysis of stage D2 prostatic carcinoma.
    Yokogi H; Mizutani M; Ishibe T
    Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometry analysis of the DNA content of the prostate cancer--study on the tumor heterogeneity in prostate cancer].
    Michinaga S; Ariyoshi A; Kinjo M; Sagiyama K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):937-41. PubMed ID: 8753013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image and flow DNA cytometry of small cell carcinoma of the lung.
    Oud PS; Pahlplatz MM; Beck JL; Wiersma-Van Tilburg A; Wagenaar SJ; Vooijs GP
    Cancer; 1989 Sep; 64(6):1304-9. PubMed ID: 2548700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic dysplasia: significance in relation to nuclear DNA ploidy studies of prostate adenocarcinoma.
    Lieber MM
    Urology; 1989 Dec; 34(6 Suppl):43-8. PubMed ID: 2603285
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
    Jones EC; McNeal J; Bruchovsky N; de Jong G
    Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
    Fujita T; Akino H; Kanimoto Y; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Sep; 37(9):1009-16. PubMed ID: 1785407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of prostatic adenocarcinomas after hormone therapy].
    Hayashi T; Mouri J; Kurosu S; Chiba R; Yokota T; Yamaguchi S
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):339-45. PubMed ID: 8121119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T; Lindgren A
    Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate.
    O'Malley FP; Grignon DJ; Keeney M; Kerkvliet N; McLean C
    Cancer; 1993 May; 71(9):2797-802. PubMed ID: 8467459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
    Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.